Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × tazemetostat × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 6 Sarcoma 3 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Inhibition, Psychological 1 Immunoblastic Lymphadenopathy 1

Interventions

Dexamethasone 108 Lenalidomide 73 daratumumab 59 Bortezomib 49 pomalidomide 40 carfilzomib 39 Calcium Dobesilate 38 Cyclophosphamide 27 Specimen Handling 25 Biopsy 23 talquetamab 19 isatuximab 19 Magnetic Resonance Spectroscopy 19 fludarabine 17 iberdomide 15 dexamethasone acetate 14 dexamethasone 21-phosphate 14 belantamab mafodotin 14 auricularum 14 selinexor 13 elotuzumab 10 tocilizumab 9 fludarabine phosphate 8 trametinib 6 ixazomib 6 X-Rays 6 Melphalan 6 venetoclax 5 Whole-Body Irradiation 5 nirogacestat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡